Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Breast Cancer
Interventions: DRUG: Vinflunine|DRUG: Trastuzumab
Sponsor: SCRI Development Innovations, LLC
Collaborators: Bristol-Myers Squibb